The UIC Embryonic Stem Cell Review Committee (ESCRO) committee reviews research proposals involving the use of human embryonic stem cells (hES). The ESCRO committee is responsible for the oversight of all hES research being conducted at or supported by UIC to ensure that it meets the National Academy of Science (NAS) guidelines. Additionally, the ESCRO committee will have the responsibility for maintaining a registry of all hES cell lines that are imported into or maintained at the UIC, including the NIH-approved hES lines.

In accordance with the NAS guidelines, the ESCRO committee includes "representatives of the public and persons with expertise in developmental biology, stem cell research, molecular biology, assisted reproduction, and ethical and legal issues in hES cell research."

 

ESCRO Announcements

MTEC Funding Opportunities for Faculty

Mar 10

UIC is a member of the Medical Technology Enterprise Consortium (MTEC).  This relatively new enterprise will provide funding opportunities in the following areas of research that may be of interest:

New rules pertaining to Clinicaltrials.gov

Dec 22

TO:  Research Advisory Council

FROM: Lisa Pitler, Assistant Vice Chancellor for Research

RE: New rules pertaining to Clinicaltrials.gov

The Final Rule for Clinical Trials Registration and Results Submission (42 CFR Part 11) and the NIH Policy on Dissemination of NIH-Funded Clinical Trial Information become effective for clinical trials initiated on or after January 18, 2017.  Additional information is available at the following websites: 

https://prsinfo.clinicaltrials.gov,